4.7
[]. Carlos Hoyo-Vadillo, et al. Metabolism of omeprazole after two oral doses in children to months old. Proc West Pharmacol Soc. 200:48:08-.
[2]. Eileen B Lawson, et al. Omeprazole limited sampling strategies to predict area under the concentration-time curve ratios: implications for cytochrome P40 2C and 3A phenotyping. Eur J Clin Pharmacol. 202 Apr;8(4):407-3.
[3]. Lan Fan, et al. Herbal medicine yin zhi huang induces CYP3A4-mediated sulfoxidation and CYP2C-dependent hydroxylation of omeprazole. Acta Pharmacol Sin. 2007 Oct;28(0):8-2.
[4]. Marcelo Ribani, et al. Validation of chromatographic methods: evaluation of detection and quantification limits in the determination of impurities in omeprazole. J Chromatogr A. 2007 Jul 3;(-2):20-.
[]. Matthias Schwab, et al. Esomeprazole-induced healing of gastroesophageal reflux disease is unrelated to the genotype of CYP2C: evidence from clinical and pharmacokinetic data. Clin Pharmacol Ther. 200 Dec;78():27-34.

H302-H402-H4
P24-P270-P273-P3-P0
![]()
![]()